A phase 1, randomized, double-blind, placebo-controlled study investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending doses of VNA-318 in healthy male subjects

计划入组 92 人 · 首次发布于 2024 年 12 月 6 日

Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)

计划入组 50 人 · 首次发布于 2023 年 9 月 7 日

Influences of DNAR Order Prohibition on Hospital Discharged Ratios and Neurological Outcomes at Discharge

计划入组 266 人 · 首次发布于 2015 年 10 月 23 日

TXB4-BC1

TXB4-BC2

TXB4-LS1

Shark-Derived VNARs Show Promise in Targeting CD20 for Lymphoma Therapy

Leveragen Secures Japanese Patent for Singularity Platform Single-Domain Antibody Discovery Technology

FDA Authorizes Emergency Compassionate Use of VAR 200 for Ultra-Rare ApoCII Amyloidosis